USANA Health Sciences : Investor Overview Q3 2024
USNA
INVESTOR
OVERVIEW
NYSE: USNA
October 2024
USANA At-A-Glance
USANA develops and manufactures high-quality,science-based nutritional and personal care products with a primary focus on promoting long-term health and wellness.
Headquarters:
Salt Lake City, Utah
Founded:
1992
Full-Time
Employees:
1,800
Annual Revenue:
$875M¹
Market Cap:
$650M²
¹ 2024 Q3 TTM
² As of 10/22/24
Product Mix¹
Nutritionals 87%
All Other
Foods
1%
6%
Skincare
6%
Geographic Mix¹
North
Asia
10%
Americas
Greater
China
53%
Southeast
Asia
Pacific
17%
2
Numbers may not sum to 100% due to rounding
Key Investment Highlights
3
BUSINESS MODEL
OVERVIEW
5-Pronged Approach to Profitable Growth
Active Customer
Growth
New Market
Expansion
and M&A
Long-Term
Profitable
Growth
Direct
Selling
Model
Product Quality
In-House
& Innovation
Manufacturing
5
Active Customers
Key leading indicator for sales momentum
Associates
Preferred Customers*
Active Customers
Independent
Customers
Associates and
Preferred Customers
distributors of
who purchase
who have purchased
USANA
USANA
from USANA any time
products who
products
during the most
also purchase
strictly for
recent three-month
for personal use
personal use
period
6
*China utilizes a Preferred Customer program that has been implemented specifically for that market.
Direct Selling Model:
A Key Driver of Operating Leverage
USANA distributes its products internationally through a direct sales network of individual business owners (Associates).
Relatively low
Associate incentives and
incremental cost to add
commissions for product sales
a new active customer
aligned w/ sales performance
USANA Direct
Selling Model
Strong cash
Ability to expand into new
generation
international markets with
moderate investment
7
In-House Manufacturing: A Key Differentiator
67% of products are manufactured in-house
GMP manufacturing facility is designed to pharmaceutical standards
8
High-Quality,Science-Based Products…
Product formulations based on the latest scientific research
Highest quality raw ingredients for optimal bioavailability
9
Disclaimer
USANA Health Sciences Inc. published this content on October 22, 2024, and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on October 22, 2024 at 23:34:06.066.